Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (02566) published a Next Day Disclosure Return dated 11 February 2026. According to the document, the company reported an opening balance (as of 10 February 2026) of 105,248,985 issued shares (excluding treasury shares) and 3,847,800 treasury shares, making the total number of issued shares 109,096,785.

On 11 February 2026, 8,600 shares were repurchased on the Exchange and classified as treasury shares. The highest repurchase price per share was HKD 9.9, with a lowest price of HKD 9.89. The transaction amounted to HKD 85,107.9994 in total. After this repurchase, the closing balance (as of 11 February 2026) stands at 105,240,385 issued shares (excluding treasury shares) and 3,856,400 treasury shares, keeping the total number of issued shares unchanged at 109,096,785.

The repurchase took place under the share repurchase mandate dated 11 June 2025, which authorized up to 10,909,678 shares for repurchase. As noted in the disclosure, 3,856,400 shares, representing approximately 3.53% of the issuer’s total issued shares (excluding treasury shares) at the time the mandate was granted, have been repurchased on the Exchange or another stock exchange since the mandate was approved.